CareRx Statistics
Total Valuation
CareRx has a market cap or net worth of 124.57 million. The enterprise value is 176.41 million.
| Market Cap | 124.57M |
| Enterprise Value | 176.41M |
Important Dates
The last earnings date was Friday, May 9, 2025.
| Earnings Date | May 9, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 63.00M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +4.25% |
| Shares Change (QoQ) | +6.98% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 29.10M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 126.85 |
| PS Ratio | 0.49 |
| PB Ratio | 2.07 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 6.06 |
| P/OCF Ratio | 4.96 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.63, with an EV/FCF ratio of 8.59.
| EV / Earnings | -67.49 |
| EV / Sales | 0.66 |
| EV / EBITDA | 9.63 |
| EV / EBIT | 33.93 |
| EV / FCF | 8.59 |
Financial Position
The company has a current ratio of 1.07, with a Debt / Equity ratio of 0.95.
| Current Ratio | 1.07 |
| Quick Ratio | 0.72 |
| Debt / Equity | 0.95 |
| Debt / EBITDA | 3.27 |
| Debt / FCF | 2.79 |
| Interest Coverage | 0.87 |
Financial Efficiency
Return on equity (ROE) is -4.48% and return on invested capital (ROIC) is 2.57%.
| Return on Equity (ROE) | -4.48% |
| Return on Assets (ROA) | 1.98% |
| Return on Invested Capital (ROIC) | 2.57% |
| Return on Capital Employed (ROCE) | 4.40% |
| Revenue Per Employee | 173,948 |
| Profits Per Employee | -1,783 |
| Employee Count | 1,508 |
| Asset Turnover | 1.62 |
| Inventory Turnover | 13.64 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +13.87% in the last 52 weeks. The beta is 0.53, so CareRx's price volatility has been lower than the market average.
| Beta (5Y) | 0.53 |
| 52-Week Price Change | +13.87% |
| 50-Day Moving Average | 1.91 |
| 200-Day Moving Average | 1.64 |
| Relative Strength Index (RSI) | 65.86 |
| Average Volume (20 Days) | 178 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CareRx had revenue of 255.01 million and -2.61 million in losses. Loss per share was -0.04.
| Revenue | 255.01M |
| Gross Profit | 75.30M |
| Operating Income | 4.98M |
| Pretax Income | -2.59M |
| Net Income | -2.61M |
| EBITDA | 14.89M |
| EBIT | 4.98M |
| Loss Per Share | -0.04 |
Balance Sheet
The company has 7.77 million in cash and 57.39 million in debt, giving a net cash position of -49.62 million.
| Cash & Cash Equivalents | 7.77M |
| Total Debt | 57.39M |
| Net Cash | -49.62M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 60.11M |
| Book Value Per Share | 0.96 |
| Working Capital | 2.89M |
Cash Flow
In the last 12 months, operating cash flow was 25.11 million and capital expenditures -4.57 million, giving a free cash flow of 20.54 million.
| Operating Cash Flow | 25.11M |
| Capital Expenditures | -4.57M |
| Free Cash Flow | 20.54M |
| FCF Per Share | n/a |
Margins
Gross margin is 29.53%, with operating and profit margins of 1.95% and -1.03%.
| Gross Margin | 29.53% |
| Operating Margin | 1.95% |
| Pretax Margin | -1.02% |
| Profit Margin | -1.03% |
| EBITDA Margin | 5.84% |
| EBIT Margin | 1.95% |
| FCF Margin | 8.06% |
Dividends & Yields
CareRx does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.25% |
| Shareholder Yield | n/a |
| Earnings Yield | -2.10% |
| FCF Yield | 16.49% |
Stock Splits
The last stock split was on June 25, 2020. It was a reverse split with a ratio of 0.05.
| Last Split Date | Jun 25, 2020 |
| Split Type | Reverse |
| Split Ratio | 0.05 |
Scores
CareRx has an Altman Z-Score of 0.55. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.55 |
| Piotroski F-Score | n/a |